Watching Aethlon Medical; Zacks Small-Cap Research Sets $5 Price Target
Portfolio Pulse from Happy Mohamed
Zacks Small-Cap Research has set a $5 price target for Aethlon Medical (AEMD), a medical device company focused on developing innovative treatments for life-threatening diseases.

June 08, 2023 | 5:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aethlon Medical's stock price may be positively impacted by Zacks Small-Cap Research's $5 price target, indicating potential growth.
Zacks Small-Cap Research, a reputable research firm, has set a $5 price target for AEMD. This price target suggests potential growth for the stock, which may lead to a positive short-term impact on AEMD's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100